For instance, bispecific CAR-T cells targeting HER2 and the melanocytic protein (gp100) can eradicate various large solid tumors, including orthotopic mammary tumors expressing HER2 in the breast and brain of immunocompetent mice (49). This evidence concerns the gene ERBB2 and breast cancer.